Montrium has announced that Orphazyme, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, has chosen to extend Montrium’s eTMF Connect and RegDocs Connect solutions with Quality Connect to empower end-to-end commercialization processes.
With a growing team and potential for several registration studies occurring in the near-future, managing critical regulated content is a key priority for Orphazyme’s clinical teams. After determining a cloud-based system would bring unique benefits, Orphazyme’s team completed a thorough assessment of solutions on the market and selected Montrium as their strategic partner.
Montrium’s eTMF Connect application is a modern electronic Trial Master File solution that has been designed specifically for life sciences organizations to manage their clinical trial documentation. Seamlessly connected with eTMF Connect, RegDocs Connect is a regulatory submissions management tool.
In addition to the eTMF Connect & Reg Docs Connect applications, Orphazyme has also decided to expand its partnership with Montrium by selecting Quality Connect, an electronic quality management system. By leveraging Montrium’s Connect platform, Orphazyme has unified clinical, regulatory and quality activities in the cloud to modernize their core business processes.
Paul Fenton, Montrium’s Chief Executive Officer, shares, “When sponsors bring on a new software vendor like Montrium, it’s as if they bring on an extension to their team. We’re incredibly excited about partnering with such a well-established organization like Orphazyme to help them achieve their commercial goals as well as building on an existing community of Montrium customers in the Scandinavian region.”
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.